Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial toxicity and lactic acidosis

    Project Inform Perspective
    |May 30, 2003
    PubMed
    Summary

    Mitochondrial toxicity, a side effect of anti-HIV drugs, may cause lactic acidosis and lipodystrophy. Further research is needed to confirm these links and understand their impact on patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Everything antiretroviral: 5th IAS conference, Cape Town, South Africa.

    Project Inform perspective·2012
    Same journal

    Well implemented, President Obama's national HIV/AIDS strategy is precisely what is needed to further control HIV/AIDS.

    Project Inform perspective·2011
    Same journal

    Finding health care; preparing for the future.

    Project Inform perspective·2011
    Same journal

    Protecting people with HIV in the California budget.

    Project Inform perspective·2010
    Same journal

    Current drugs in clinical study.

    Project Inform perspective·2010
    Same journal

    HIV treatment information.

    Project Inform perspective·2010

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Cell Biology

    Background:

    • Mitochondrial toxicity is an emerging concern with anti-HIV drug therapies.
    • Lactic acidosis is a recognized symptom potentially linked to mitochondrial dysfunction.
    • Fat redistribution syndrome (lipodystrophy) is a common side effect in patients on anti-HIV medications.

    Discussion:

    • Exploring the biochemical pathways connecting anti-HIV drug-induced mitochondrial damage to lactic acidosis.
    • Investigating the hypothesis that mitochondrial dysfunction contributes to the development of lipodystrophy.
    • Analyzing the clinical implications of these interconnected side effects in HIV management.

    Key Insights:

    • Mitochondrial toxicity is increasingly implicated as a cause of lactic acidosis in patients receiving anti-HIV therapy.
    • A potential causal link exists between mitochondrial damage and the fat redistribution (lipodystrophy) observed in HIV patients.
    • Understanding these mechanisms is crucial for improving the safety and efficacy of long-term HIV treatment.

    Outlook:

    • Further research is essential to elucidate the precise mechanisms of mitochondrial toxicity, lactic acidosis, and lipodystrophy.
    • Development of novel anti-HIV drugs with reduced mitochondrial toxicity is a key future direction.
    • Longitudinal studies are needed to assess the long-term consequences and management strategies for these side effects.

    Related Experiment Videos